The Pathogenesis, Epidemiology and Management of Glucocorticoid-Induced Osteoporosis

ISSN： 0171-967X

Source： Calcified Tissue International, Vol.79, Iss.3, 2006-09, pp. : 129-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glucocorticoid-induced Osteoporosis

By Manelli F.F. Giustina A.A.

Trends in Endocrinology and Metabolism, Vol. 11, Iss. 3, 2000-04 ,pp. : 79-85

Elsevier

Access to resources Recommend Favorite

Alphacalcidol in Prevention of Glucocorticoid-Induced Osteoporosis

By Reginster J. Y. de Froidmont C. Lecart M.-P. Sarlet N. Defraigne J.-O.

Calcified Tissue International, Vol. 65, Iss. 4, 1999-10 ,pp. : 328-331

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Glucocorticoid-Induced Osteoporosis with Alfacalcidol/Calcium Versus Vitamin D/Calcium

By Ringe J. D. Cöster A. Meng T. Schacht E. Umbach R.

Calcified Tissue International, Vol. 65, Iss. 4, 1999-10 ,pp. : 337-340

Springer Publishing Company

Access to resources Recommend Favorite

Glucocorticoid-induced osteonecrosis

By Weinstein Robert

Endocrine, Vol. 41, Iss. 2, 2012-04 ,pp. : 183-190

Springer Publishing Company

Access to resources Recommend Favorite

Prevention and treatment strategies for glucocorticoid-induced osteoporotic fractures

By Gourlay Margaret Franceschini Nora Sheyn Yevgeniy

Clinical Rheumatology, Vol. 26, Iss. 2, 2007-02 ,pp. : 144-153

Springer Publishing Company

Access to resources Recommend Favorite